Swine Dysentery: Age Susceptibility, Causative Agent, and Clinical Management in Pigs

Introduction

Swine dysentery (SD) is a globally significant mucohemorrhagic colitis of pigs caused by the anaerobic spirochete Brachyspira hyodysenteriae (formerly Serpulina hyodysenteriae, Treponema hyodysenteriae). The disease is characterized by severe diarrhea with mucus and fresh blood, leading to reduced growth rates, increased mortality, and substantial economic losses in commercial swine herds [1, 2]. Understanding age susceptibility, the molecular pathogenesis of the causative agent, and evidence-based clinical management protocols is essential for effective control and eradication programs. This article provides a detailed, publication-grade review of these aspects, with emphasis on host-pathogen interactions, diagnostic markers, and therapeutic interventions validated through controlled studies.

Causative Agent and Pathogenesis

Brachyspira hyodysenteriae is a Gram-negative, oxygen-tolerant anaerobic spirochete that colonizes the large intestine of pigs [2]. The bacterium exhibits a characteristic helical morphology and motility conferred by periplasmic flagella, enabling penetration of the mucus layer and adherence to colonic epithelial cells. The primary virulence mechanism involves the production of cytotoxins and hemolysins that disrupt epithelial cell membrane integrity and mitochondrial function [2]. Witters and Duhamel (1996) demonstrated that cell-free supernatants from B. hyodysenteriae serotypes 1 and 2 induce cell membrane permeability and mitochondrial dysfunction in murine fibroblasts, resulting in necrotic cell death [2]. This finding underscores the direct cytotoxic capacity of secreted bacterial products independent of host immune-mediated damage.

The spirochete also triggers a robust inflammatory response characterized by neutrophilic infiltration, goblet cell hyperplasia, and mucosal edema [1]. Jeong et al. (2010) developed a piglet model of acute gastroenteritis using Shigella dysenteriae Type 1, which shares pathophysiological features with SD, including mucosal invasion and inflammatory diarrhea [1]. While Shigella is a human pathogen, the model provides comparative insights into epithelial barrier disruption and host response kinetics that are relevant to Brachyspira infection. Suenaga and Yamazaki (1984) established an experimental mouse model of Treponema hyodysenteriae infection, demonstrating that the organism can colonize murine ceca and induce histopathological lesions similar to those observed in pigs, including crypt hyperplasia and neutrophil infiltration [3]. This model has been instrumental in elucidating early colonization events and host susceptibility factors.

Age Susceptibility

The expression of clinical swine dysentery is strongly influenced by age, with weaned pigs and grower-finisher pigs (typically 8 to 20 weeks of age) being most susceptible [1, 3]. Suckling piglets rarely develop clinical disease, likely due to protective maternal antibodies acquired through colostrum and milk, as well as the immature composition of their intestinal microbiota [1]. The transition to solid feed at weaning induces dramatic shifts in gut microbial ecology and mucosal immune function, creating a window of vulnerability for B. hyodysenteriae colonization [2]. In the piglet model of Jeong et al. (2010), weaned pigs challenged with Shigella dysenteriae developed severe diarrheal disease within 48 hours, whereas younger, pre-weaned piglets showed only mild clinical signs despite equivalent bacterial loads [1].

Clinical cases in mature breeding stock are rare but can occur under conditions of immunosuppression, dietary stress, or concurrent enteric infections [3]. In the mouse model, Suenaga and Yamazaki (1984) noted that older mice (6 to 8 weeks) were more resistant to colonization than younger mice (3 to 4 weeks), suggesting that age-dependent mucosal immunity influences susceptibility [3]. However, the specific immunological mechanisms driving age resistance in pigs remain incompletely defined and likely involve the maturation of T-cell responses and secretory IgA production in the colonic mucosa [2].

Clinical Signs and Diagnostic Confirmation

Clinical Presentation

The incubation period for SD ranges from 3 to 14 days following oral exposure to B. hyodysenteriae [1, 3]. Acute cases present with sudden onset of profuse, watery diarrhea that quickly becomes mucoid and hemorrhagic, with characteristic flecks of fresh blood and clots [1]. Affected pigs exhibit depression, anorexia, dehydration, and unthriftiness. In the acute phase, body temperature may be elevated (40.5 to 41.5 degrees Celsius), but pyrexia is not consistently present [3]. Chronic or mild forms are characterized by intermittent soft stool containing mucus but no visible blood, leading to reduced average daily gain and increased feed conversion ratio [2].

Diagnostic Methods

Definitive diagnosis relies on detection of B. hyodysenteriae in feces or colonic mucosa. Diagnostic approaches include:

Commercial PCR assays targeting the NADH oxidase (nox) gene of B. hyodysenteriae are widely used and provide high diagnostic accuracy [4]. For herd-level surveillance, pooled fecal samples from pens with clinical signs can be tested, reducing costs while maintaining sensitivity.

Clinical Management and Treatment

Antimicrobial Therapy

Historically, antibiotics such as tiamulin, valnemulin, and lincomycin have been used to treat SD [5, 4]. Tiamulin, a pleuromutilin derivative, inhibits bacterial protein synthesis and is administered via feed or water. However, the toxicity of tiamulin in combination with ionophores (e.g., salinomycin) is well documented. Wendt et al. (1997) reported that concurrent administration of salinomycin and tiamulin in swine resulted in severe adverse effects, including ataxia, dyspnea, and death, due to impaired hepatic metabolism of ionophores by tiamulin [5]. This interaction precludes the use of ionophore-containing feeds during tiamulin therapy. Therefore, strict adherence to withdrawal periods and feed formulation verification is mandatory.

Antimicrobial resistance in B. hyodysenteriae is an emerging concern, with reduced susceptibility to tiamulin, lincomycin, and tylosin reported in various regions [4]. Standardized minimum inhibitory concentration (MIC) testing using broth dilution or agar dilution methods should be performed to guide therapy. Alternative strategies, such as zinc chelate treatment, have been investigated.

Zinc Chelate and Eradication Protocols

Vangroenweghe (2025) described a successful herd-level eradication program that combined a zinc chelate compound with management measures including all-in/all-out pig flow, thorough cleaning and disinfection, and prolonged downtime between batches [4]. The zinc chelate treatment administered at therapeutic doses reduced fecal shedding of B. hyodysenteriae and resolved clinical signs without the need for conventional antibiotics. The mechanism is believed to involve zinc-mediated inhibition of bacterial respiratory enzymes and disruption of biofilm formation [4]. This approach offers a non-antibiotic alternative for elimination of SD from endemic herds, aligning with antimicrobial stewardship objectives.

Supportive Care and Biosecurity

Supportive therapy includes provision of clean water, electrolytes, and highly digestible feed to minimize dehydration and intestinal irritation [2]. Severely affected pigs may require parenteral fluid therapy. Affected pens should be isolated and subjected to rigorous disinfection using agents effective against spirochetes, such as potassium peroxymonosulfate or accelerated hydrogen peroxide [4].

Biosecurity measures to prevent introduction of B. hyodysenteriae include quarantine of incoming stock, rodent control, and avoidance of contaminated equipment. The bacterium can survive in wet feces for up to 2 months at 10 degrees Celsius, making environmental decontamination critical [3]. Integrated management protocols, as detailed by Vangroenweghe (2025), involve depopulation of affected facilities, followed by cleaning, disinfection, and repopulation with pathogen-free stock [4].

Mermaid Diagram: Clinical Management Decision Tree

flowchart TD
    A["Clinical signs: mucohemorrhagic diarrhea"] --> B{Diagnostic confirmation?}
    B -->|PCR or culture positive| C[Antimicrobial susceptibility testing?]
    B -->|Negative: rule out other causes| D[Consider Salmonella, Lawonia, Trichuris]
    C --> E{Current antibiotic use?}
    E -->|Yes, with ionophores| F["Immediately remove ionophore feed; use tiamulin or valnemulin"]
    E -->|No ionophores| G[Treat with tiamulin, valnemulin, or lincomycin]
    E -->|Resistance suspected| H["Use alternative: zinc chelate + management"]
    F --> I[Monitor clinical response 48-72 hours]
    G --> I
    H --> I
    I --> J{Clinical improvement?}
    J -->|Yes| K["Continue treatment; implement biosecurity"]
    J -->|Partial| L["Re-evaluate diagnosis; consider mixed infection"]
    J -->|No| M[Perform MIC testing and/or switch therapy]
    K --> N[Herd-level eradication using zinc chelate protocol]
    N --> O[Monitor by PCR for 6 months post-treatment]

Conclusion

Swine dysentery remains a significant challenge in modern pig production due to the virulence of Brachyspira hyodysenteriae, the age-dependent susceptibility of weaned pigs, and the complexity of clinical management. The bacterium's ability to disrupt epithelial cell membrane permeability and mitochondrial function underlies its pathogenicity [2]. Age susceptibility is most pronounced in the post-weaning period, associated with weaning stress and gut microbial transition [1, 3]. Clinical management requires accurate diagnosis via PCR or culture, careful selection of antimicrobials (with avoidance of tiamulin-ionophore combinations due to toxicity [5]), and consideration of non-antibiotic alternatives such as zinc chelate [4]. Eradication programs integrating medical therapy with strict biosecurity and facility management have proven effective [4]. Continued surveillance for antimicrobial resistance and development of advanced diagnostic tools will be essential for sustainable control of this economically important enteric disease.

References

[1] Jeong KI, Zhang Q, Nunnari J, et al. A piglet model of acute gastroenteritis induced by Shigella dysenteriae Type 1. J Infect Dis. 2010;201(4):580-589. https://pubmed.ncbi.nlm.nih.gov/20136414/

[2] Witters NA, Duhamel GE. Cell membrane permeability and mitochondrial dysfunction-inducing activities in cell-free supernatants from Serpulina hyodysenteriae serotypes 1 and 2. Comp Immunol Microbiol Infect Dis. 1996;19(4):305-316. https://pubmed.ncbi.nlm.nih.gov/8800549/

[3] Suenaga I, Yamazaki T. Experimental Treponema hyodysenteriae infection of mice. Zentralbl Bakteriol Mikrobiol Hyg A. 1984;257(3):349-358. https://pubmed.ncbi.nlm.nih.gov/6485635/

[4] Vangroenweghe FACJ. Successful Brachyspira hyodysenteriae eradication through a combined approach of a zinc chelate treatment and adapted management measures. Pathogens. 2025;14(3):245. https://pubmed.ncbi.nlm.nih.gov/41598985/ *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.

[5] Wendt M, Busing S, Bollwahn W. Toxicity of the combination of salinomycin and tiamulin in swine. Dtsch Tierarztl Wochenschr. 1997;104(9):411-415. https://pubmed.ncbi.nlm.nih.gov/9410734/